|
|
||||||||
From the Departments of Medicine, and of Obstetrics and Gynecology, and The Blood Bank, New York Hospital—Cornell University Medical Center, New York, NY
Abstract
A safe method for intrauterine transfusion utilizing maternal blood has been described. Results indicate that neither transfer of maternal Rh antibody to the fetus, nor potential fetal maternal ABO incompatibility is hazardous to the fetus. This method eliminates the risk of maternal homologous serum hepatitis and isoimmunization to other blood group factors. It is advocated for intrauterine transfusions provided that the maternal hematocrit is 35% or greater and no more than 150 ml of blood are withdrawn for each procedure.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |